Recruiting Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells NCT05691465 Conditions Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +11 more Locations City of Hope Comprehensive Cancer Center — Duarte, California, United States Los Angeles General Medical Center — Los Angeles, California, United States USC / Norris Comprehensive Cancer Center — Los Angeles, California, United States University of California Davis Comprehensive Cancer Center — Sacramento, California, United States View all 13 locations View more locations Show fewer locations Loading locations... View Trial Details
Active, Not Recruiting Testing Two Oral Drugs Combination (Cediranib and Olaparib) Compared to a Single Drug (Olaparib) for Men With Advanced Prostate Cancer NCT02893917 Conditions Advanced Prostate Adenocarcinoma With Neuroendocrine Differentiation, Castration-Resistant Prostate Carcinoma, Genital Diseases, +13 more Locations UC San Diego Moores Cancer Center — La Jolla, California, United States University of California Davis Comprehensive Cancer Center — Sacramento, California, United States UC San Diego Medical Center - Hillcrest — San Diego, California, United States Smilow Cancer Center/Yale-New Haven Hospital — New Haven, Connecticut, United States View all 16 locations View more locations Show fewer locations Loading locations... View Trial Details
